Fortress Biotech Inc banner

Fortress Biotech Inc
NASDAQ:FBIO

Watchlist Manager
Fortress Biotech Inc Logo
Fortress Biotech Inc
NASDAQ:FBIO
Watchlist
Price: 3.16 USD 1.28% Market Closed
Market Cap: $98.1m

During the last 3 months Fortress Biotech Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 11% over this period (open performance analysis).

The last transaction was made on Sep 23, 2024 by Rosenwald Lindsay A Md , who bought 1.4m USD worth of FBIO shares.

Last Transactions:
Rosenwald Lindsay A Md
$+1.4m
Rosenwald Lindsay A Md
$+37.4k
Jin David
$+3.8k
Rosenwald Lindsay A Md
$+37k
Rosenwald Lindsay A Md
$+36.8k
Rosenwald Lindsay A Md
$+32.7k
Klein Dov
$-18.9k
Rosenwald Lindsay A Md
$+17.6k
Rosenwald Lindsay A Md
$+118.8k
Rosenwald Lindsay A Md
$+2.7m
Weiss Michael S
$+250k
Rosenwald Lindsay A Md
$+1.9k
Rosenwald Lindsay A Md
$+6.2k
Rosenwald Lindsay A Md
$+7.8k
Rosenwald Lindsay A Md
$+133.3k
Lu Lucy
$+666.3
Jin David
$+2k
Rowinsky Eric K
$+666.3
Lobell J Jay
$+16.7k
Weiss Michael S
$+66.7k
Rosenwald Lindsay A Md
$+453.3
Rosenwald Lindsay A Md
$+18.5
Jin David
$+18.5
Rosenwald Lindsay A Md
$+463.6
Klein Dov
$-80.9
Hunter Robyn
$-591.6
Rowinsky Eric K
$-298.2
Rowinsky Eric K
$-228.4
Rowinsky Eric K
$-168
Rowinsky Eric K
$-50.2
Rowinsky Eric K
$-102.6
Hunter Robyn
$-832.2
View All Transactions

During the last 3 months Fortress Biotech Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 11% over this period (open performance analysis).

The last transaction was made on Sep 23, 2024 by Rosenwald Lindsay A Md , who bought 1.4m USD worth of FBIO shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Fortress Biotech Inc
Insider Trading Chart

Fortress Biotech Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Fortress Biotech Inc
Last Insider Transactions

Global
Insiders Monitor

Fortress Biotech Inc
Glance View

Market Cap
98.1m USD
Industry
Biotechnology

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. The company is headquartered in Bay Harbor Islands, Florida and currently employs 173 full-time employees. The company went IPO on 2011-11-17. Fortress has seven marketed prescription pharmaceutical products and over 25 programs in development at Fortress, and at its partner companies. Its product candidates span six market areas, including oncology, rare diseases and gene therapy. The firm's commercialized products include Ximino, Targadox, Exelderm, Ceracade, Luxamend and Accutane. Its late-stage product candidates include Intravenous (IV) Tramadol, CUTX-101, MB-107 and MB-207, Cosibelimab, CK-101, CAEL-101, Triplex and CEVA101. Its product candidates also consist of MB-102 (CD123 CAR T for BPDCN), MB-101 (IL13Ra2 CAR T for Glioblastoma), MB-104, MB-106, MB-103, AVTS-001, CK-103 and ConVax. The firm operates in two operating and reportable segments: Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

FBIO Intrinsic Value
6.06 USD
Undervaluation 48%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett